miRagen Therapeutics, Inc. - Product Pipeline Review - 2012 New Report


Naperville, IL -- (SBWIRE) -- 09/25/2012 -- miRagen Therapeutics, Inc. - Product Pipeline Review - 2012 provides data on the miRagen Therapeutics, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.


- miRagen Therapeutics, Inc. - Brief miRagen Therapeutics, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of miRagen Therapeutics, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of miRagen Therapeutics, Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the miRagen Therapeutics, Inc.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate miRagen Therapeutics, Inc.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of miRagen Therapeutics, Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the miRagen Therapeutics, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with miRagen Therapeutics, Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of miRagen Therapeutics, Inc. and identify potential opportunities in those areas.


Current R&D Portfolio of miRagen Therapeutics, Inc.; miRagen Therapeutics, Inc. - Key Therapeutics; miRagen Therapeutics, Inc. - Pipeline Overview and Promising Molecules; miRagen Therapeutics, Inc. - News; miRagen Therapeutics, Inc. - Latest Updates; miRagen Therapeutics, Inc. - Pipeline; miRagen Therapeutics, Inc. - Discontinued/Dormant Projects

To view table of contents for this market report please visit: